The dog vaccine market is projected to grow from USD 2.0 billion in 2025 to USD 3.5 billion by 2035, at a CAGR of 5.8%. Live attenuated will dominate with a 46.3% market share, while canine distemper will lead the disease type segment with a 28.7% share.